Groundbreaking research finds dropping the third stage of standard MRI test for the disease doesn’t hamper detection rates, and cuts costs in half
Cutting the duration of MRI scans for prostate cancer by a third would make them cheaper and more accessible without reducing their accuracy. That is the key result of a UK trial which indicates that lowering costs could ensure more men are offered scans.
According to Cancer Research UK, there are about 52,300 new prostate cancer cases every year in the UK, equal to more than 140 a day.
